Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Medical Cannabis and Wellness Equity |
| Investeringsfocus | Equity, North America, Health Care |
| Fondsgrootte | EUR 12 m |
| Totale kostenratio (TER) | 0.80% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Strategierisico | Langdurig |
| Duurzaamheid | No |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 33.41% |
| Startdatum/Noteringsdatum | 9 January 2020 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ireland |
| Fondsaanbieder | HANetf |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | J.P. Morgan Administration Services (Ireland) Limited |
| Beleggingsadviseur | |
| Bewaarbank | J.P. Morgan SE - Dublin Branch |
| Revisiebedrijf | Ernst and Young |
| Einde belastingjaar | 31 March |
| Vertegenwoordiger van Zwitserland | Waystone |
| Zwitserse uitbetalende instantie | Helvetische Bank AG |
| Duitsland | 30% tax rebate |
| Zwitserland | No ESTV Reporting |
| Oostenrijk | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
| Jazz Pharmaceuticals | 22,81% |
| Scotts Miracle-Gro Co. | 18,83% |
| Turning Point Brands | 14,70% |
| Advanced Flower Capital | 9,53% |
| Chicago Atlantic Real Est | 9,45% |
| GrowGeneration | 6,13% |
| CARA Therapeutics | 4,94% |
| WM TECHNOLOGY INC ORD | 4,62% |
| BRIGHT GREEN ORD | 2,81% |
| RELIQ HEALTH TECHNOLOGIES INC ORD | 2,18% |
| États-Unis | 72,59% |
| Irlande | 22,81% |
| Canada | 3,55% |
| Autre | 1,05% |
| Santé | 32,73% |
| Services financiers | 18,98% |
| Matières premières | 18,83% |
| Biens de consommation non cycliques | 14,70% |
| Autre | 14,76% |
| YTD | -39,40% |
| 1 maand | -11,74% |
| 3 maanden | -25,07% |
| 6 maanden | -32,56% |
| 1 jaar | -47,92% |
| 3 jaar | -61,27% |
| 5 jaar | - |
| Since inception | -62,70% |
| 2025 | -52,46% |
| 2024 | +0,77% |
| 2023 | - |
| 2022 | - |
| Volatiliteit 1 jaar | 33,41% |
| Volatiliteit 3 jaar | 34,50% |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | -1,43 |
| Rendement/Risico 3 jaar | -0,79 |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | -51,13% |
| Maximaal waardedaling 3 jaar | -81,62% |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -81,62% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | CBSX | - - | - - | - |
| London Stock Exchange | GBX | CBDP | Societe Generale | ||
| London Stock Exchange | USD | CBDX | CBDX LN | CBDX.L | Societe Generale |
| London Stock Exchange | GBP | - | CBDP LN | CBDP.L | Societe Generale |
| SIX Swiss Exchange | CHF | CBDX | CBDX SW CBSXIV | CBDX.S CBSXEURINAV=SOLA | Societe Generale |
| XETRA | EUR | CBSX | CBSX GY CBSXIV | CBSX.DE CBSXEURINAV=SOLA | Societe Generale |